English | Español
Press release submission | Dec 6, 2018

JANSSEN: DARZALEX® (daratumumab) Combination Regimens Show Positive Results for Newly Diagnosed and Relapsed Patients with Multiple Myeloma
Press release submission | Nov 26, 2018

ABBVIE: Receives US FDA Accelerated Approval for VENCLEXTA® (venetoclax) for Treatment of Newly-Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy
Press release submission | Nov 7, 2018

PARTNER THERAPEUTICS: Receives FDA Orphan Drug Designation for Leukine® for the Treatment of Pulmonary Alveolar Proteinosis
Harmony Valdoz | Aug 28, 2018

Pharmaceutical industry group backs proposal to share drug savings with Medicare beneficiaries
Press release submission | Jul 31, 2018

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: Massachusetts Joins Ranks of States Preventing Tobacco Sales to Youth Under 21, Becomes First State to Pass Tobacco Sale Ban

Press release submission | Jul 25, 2018

AMERICAN HEART ASSOCIATION: New hospital certification raises standard of care for patients with advanced heart failure
Press release submission | Jul 25, 2018

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK: ACS CAN Letter: Drug Pricing Policy Should Prioritize Patient Affordability
Press release submission | Jul 20, 2018

LUPUS FOUNDATION OF AMERICA: House Committee Approves Funding of Critical Lupus Programs

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

Coalition warns against potential impact of H.R. 1 on patient healthcare access